S. Michael Imperiale Jr M.D. a Board member at ScripsAmerica and has been with the company since 2011. He is a clinical trials expert and has worked for several major biopharmaceutical companies that have released and sold pharmaceutical drugs to the market with FDA approval to the general public.
Michael Imperiale has an extensive track record of successful clinical trial. Clinical trials take a lot of work and a lot of patience for a pharmaceutical company to get a new medicine approved. On average it will take about twelve years for an experimental medication to go from the laboratory to the intended patients in need. Not all trials are successful and, unfortunately, do not reach finishing status to help a patient in need in good time. The process is long due to the rigorous standards put in place by the Food and Drug Administration, the government agency that regulates medications in the United States.

As an already established executive leader, S. Michael Imperiale, Jr. M.D. has displayed the ability to lead and manage a team through trials and approvals. He has devoted his entire career to the biopharmaceutical drug industry and his personal life to his family and loved ones. Michael works in this industry with a sense of urgency, compassion for humans and a passion for science that is uncanny.

From 2004 to 2006, S. Michael Imperiale, Jr., served as Director of Clinical Trials Development at Exelixis Inc., where he was responsible for U.S. Food and Drug Administration clinical filings. He spent much of his time building external investigator relationships while working on oversight of oncology and nephrology clinical trial programs. He became the Vice President of Clinical Research Operations at Talon Therapeutics, Inc. from August 2007 to 2009. Following that role he served as Senior Director of Medical Sciences at Nuvelo, Inc., where he served as a clinical lead and strategy expert of the oncology program and managed the team of Medical Science Liaisons. In 2009, he served as Senior Director of Global Medical Affairs for BioMarin in Novato California. Dr. Imperiale served as a Director of InterMune, Inc. and Boehringer-Ingelheim Pharmaceutical Corporation.

About: S. Michael Imperiale Jr M.D. is a pharmaceuticals executive who is ready to climb the ladder in a chief executive role. For more information about S. Michael Imperiale Jr visit :- http://smichaelimperialejr.jigsy.com
Contact: (415) 300-6621